Share-based Compensation (Tables)

6 Months Ended

Sep. 30, 2021

Summary of share-based compensation expense for options

The following table summarizes the share-based compensation expense for SSARs, restricted and performance grants included in the condensed consolidated statements of operations:

	Three Months Ended September 30,				Six Months Ended September 30,
(In thousands)	2021		2020		2021		2020
Product development	$	1,751	$	239	$	3,816	$	411
Sales and marketing		335		34		666		70
General and administrative		1,256		983		2,481		2,201
Total share-based compensation expense	$	3,342	$	1,256	$	6,963	$	2,682

Activity related SSARs award

The following table summarizes the activity during the six months ended September 30, 2021 for SSARs awarded under the 2020 and 2016 Plans:

	Number of Rights			Weighted-Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)		(in thousands)
Outstanding at April 1, 2021		3,068,253		$	20.90
Exercised		(791,549	)		12.47
Forfeited		(44,736	)		20.02
Expired		(246	)		14.22
Outstanding at September 30, 2021		2,231,722		$	23.90		5.2	$	63,509
Exercisable at September 30, 2021		1,234,892		$	22.85		4.9	$	36,448
Vested and expected to vest at September 30, 2021		2,231,722		$	23.90		5.2	$	63,509

The following table summarizes the activity during the six months ended September 30, 2021 for restricted shares awarded under the 2020 and 2016 Plans:

	Number of Shares			Weighted-Average Grant-Date Fair Value
				(per share)
Outstanding at April 1, 2021		132,198		$	37.67
Granted		11,249			52.77
Vested		(216	)		53.32
Forfeited		(3,899	)		27.25
Outstanding at September 30, 2021		139,332		$	39.14